How do I buy Vor Biopharma Inc. Common Stock (VOR) stock?

Buying Vor Biopharma Inc. Common Stock (VOR) stock is now easy and instant through the Gotrade app. Download the Gotrade app from the App Store or Google Play. Create an account and verify your identity. Make a deposit. Search for the code "VOR", then tap "Trade". Tap the "Buy" button. Enter the amount you want to buy. You have two options: Buy VOR by number of shares. Buy fractional shares in dollars, starting from $1. Swipe up to confirm your order, and you're done!

What is the minimum investment for VOR on Gotrade?

On Gotrade , you don't have to buy a full share. With fractional shares, you can start investing in Vor Biopharma Inc. Common Stock from just $1. A small budget shouldn't stop you from building a US stock portfolio.

Does Vor Biopharma Inc. Common Stock (VOR) pay dividends?

At the moment, Vor Biopharma Inc. Common Stock (VOR) does not pay dividends because it focuses on reinvesting profits for company growth (a growth stock). However, you can still potentially earn profit from share price increases (capital gains). Track VOR's performance via the price chart in the Gotrade app.

Is buying VOR on Gotrade safe and legal?

Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA).

What are the market hours to buy VOR?

You can place an order any time. It goes through when the US market (NYSE/NASDAQ) opens: 9:30 AM to 4:00 PM New York time, Monday to Friday. Pre-market and after-hours trading are open too. The market is closed on US public holidays. The Gotrade app shows whether the market is open.

How do I tell if VOR is expensive or cheap?

There's no single perfect answer, but common approaches include: Compare valuation (e.g., P/E, P/S) against historical averages or competitors. Review revenue and earnings growth. Check margins and cash flow. Evaluate business outlook and the company's position within its industry. You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Vor Biopharma Inc. Common Stock (VOR) Stock Price: Nov 11 Close $20.09

Latest news

Reuters

Vor Bio says its experimental drug slowed loss of kidney function in late-stage study

PositiveVOROctober 22, 2026

ReutersPositive

Vor Bio says its experimental drug slowed loss of kidney function in late-stage study

VOR

Zacks Investment Research

Wall Street Analysts Believe Vor Biopharma (VOR) Could Rally 124.59%: Here's is How to Trade

VORMay 7, 2026

Zacks Investment Research

Wall Street Analysts Believe Vor Biopharma (VOR) Could Rally 124.59%: Here's is How to Trade

VOR

Zacks Investment Research

Does Vor Biopharma (VOR) Have the Potential to Rally 117% as Wall Street Analysts Expect?

VORApril 20, 2026

Zacks Investment Research

Does Vor Biopharma (VOR) Have the Potential to Rally 117% as Wall Street Analysts Expect?

VOR

Zacks Investment Research

Vor Biopharma (VOR) Upgraded to Buy: Here's Why

VORApril 2, 2026

Zacks Investment Research

Vor Biopharma (VOR) Upgraded to Buy: Here's Why

VOR

Zacks Investment Research

Wall Street Analysts Predict a 107.82% Upside in Vor Biopharma (VOR): Here's What You Should Know

VORApril 2, 2026

Zacks Investment Research

Wall Street Analysts Predict a 107.82% Upside in Vor Biopharma (VOR): Here's What You Should Know

VOR

Stocktwits

VOR Shares Rally Over 40% In Pre-Market Trade After JPMorgan Initiates Bullish Coverage

VORDecember 9, 2025

Stocktwits

VOR Shares Rally Over 40% In Pre-Market Trade After JPMorgan Initiates Bullish Coverage

VOR

Stocktwits

Futures Tread Cautiously Pre-Market As Investors Await Key Fed Decision: NVDA, XCUR, GME, CASY Among Stocks To Watch

VORDecember 9, 2025

Stocktwits

Futures Tread Cautiously Pre-Market As Investors Await Key Fed Decision: NVDA, XCUR, GME, CASY Among Stocks To Watch

VOR

Zacks Investment Research

News tone: automated (AI) classification of the article's content, not a price prediction.

About Vor Biopharma Inc. Common Stock

No description available.

SectorHealthcare

IndustryBiotechnology

Employees76

CEODr. Jean-Paul Kress M.D.

IPO DateFeb 5, 2021

HeadquartersBoston, MA

Key Executives

Name	Title	Year Born
Dr. Jean-Paul Kress M.D.	Chairman, President & CEO	1965
Dr. Siddhartha Mukherjee DPHIL, M.D., Ph.D.	Scientific Founder & Chairman of Scientific Advisory Board	1971
Mr. Sandesh Mahatme L.L.M.	Chief Business Officer & CFO	1965
Dr. Robert Ang M.B.A., M.D., MBBS	Strategic Advisor	1975
Ms. Adi Osovsky	General Counsel	—
Ms. Carol Lincoln CCP	Head of Human Resources	—
Mr. Dallan Murray	Chief Commercial Officer	1970
Dr. Navid Z. Khan Ph.D.	Chief Medical Affairs Officer	—
Dr. Jeremy Sokolove M.D.	Chief Medical Officer	1974

Fundamentals

Valuation

Price-to-book value-8.76

Profitability

Return on Equity-830.00%

Return on Assets278.00%

EBITDA$1.35B

Trading

Average volume753,669

Source: third-party data provider, as of November 13, 2026

Technical indicators

RSI 14: 52.85
MACD 12/26/9: 0.03
EMA 9 of MACD: -0.08
MACD histogram: 0.12
SMA 50: $20.20; Price below SMA 50
EMA 50: $19.85; Price above EMA 50
SMA 200: $17.48; Price above SMA 200
EMA 200: $17.24; Price above EMA 200

Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.

Analyst views

1 analyst rating

Third-party analyst opinion, not a recommendation from Gotrade.

Analyst consensus:Buy

100% Buy

0% Hold

0% Sell

Analyst price target

Low: -
Average: -
High: -

William Blair

Myles Minter

Buy

Target price

-

Seasonality

Monthly price change (%)

	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2021											-35.8	+2.7
2022	-32.5	+4.6	-31.7	-9.3	-28.6	+23.0	-4.2	+5.3	-25.0	+22.4	-1.9	+40.0
2023	-22.0	+5.5	-2.4	-14.9	+9.6	-34.8	+2.0	-21.1	-20.6	-6.4	+11.8	+17.2
2024	+3.1	-2.1	+4.4	-21.8	-23.7	-30.1	-6.1	-7.0	-16.0	+31.7	+3.4	+27.7
2025	+26.8	-19.4	-24.6	+9.5	-69.7	+590.8	+44.8	-6.2	+19.4	-38.6	-62.8	+70.3
2026	+11.7	+20.7	+12.2	-17.6	+8.1	+26.4	+15.0	+5.0	-15.7	+9.0	+1.6

Compare stocks

VOR

Buy VOR

Market cap

$1.23B

-

Price / Earnings ratio

0.90

-

Price / Sales ratio

-

Dividend yield

0.00%

-

Average volume

753,669

-

Earnings per share

$299.89

-

Vor Biopharma Inc. Common Stock (VOR) Stock

Key stats

Compare with VOR

Recent news

Vor Bio says its experimental drug slowed loss of kidney function in late-stage study

Vor Bio says its experimental drug slowed loss of kidney function in late-stage study

Wall Street Analysts Believe Vor Biopharma (VOR) Could Rally 124.59%: Here's is How to Trade

Wall Street Analysts Believe Vor Biopharma (VOR) Could Rally 124.59%: Here's is How to Trade

Does Vor Biopharma (VOR) Have the Potential to Rally 117% as Wall Street Analysts Expect?

Does Vor Biopharma (VOR) Have the Potential to Rally 117% as Wall Street Analysts Expect?

Vor Biopharma (VOR) Upgraded to Buy: Here's Why

Vor Biopharma (VOR) Upgraded to Buy: Here's Why

Technical indicators

Analyst ratings

Financials

Performance

Debt & Balance Sheet

Revenue to Profit

Earnings

Latest news

Vor Bio says its experimental drug slowed loss of kidney function in late-stage study

Vor Bio says its experimental drug slowed loss of kidney function in late-stage study

Wall Street Analysts Believe Vor Biopharma (VOR) Could Rally 124.59%: Here's is How to Trade

Wall Street Analysts Believe Vor Biopharma (VOR) Could Rally 124.59%: Here's is How to Trade

Does Vor Biopharma (VOR) Have the Potential to Rally 117% as Wall Street Analysts Expect?

Does Vor Biopharma (VOR) Have the Potential to Rally 117% as Wall Street Analysts Expect?

Vor Biopharma (VOR) Upgraded to Buy: Here's Why

Vor Biopharma (VOR) Upgraded to Buy: Here's Why

Wall Street Analysts Predict a 107.82% Upside in Vor Biopharma (VOR): Here's What You Should Know

Wall Street Analysts Predict a 107.82% Upside in Vor Biopharma (VOR): Here's What You Should Know

VOR Shares Rally Over 40% In Pre-Market Trade After JPMorgan Initiates Bullish Coverage

VOR Shares Rally Over 40% In Pre-Market Trade After JPMorgan Initiates Bullish Coverage

Futures Tread Cautiously Pre-Market As Investors Await Key Fed Decision: NVDA, XCUR, GME, CASY Among Stocks To Watch

Futures Tread Cautiously Pre-Market As Investors Await Key Fed Decision: NVDA, XCUR, GME, CASY Among Stocks To Watch

Vor Biopharma (VOR) Upgraded to Buy: Here's What You Should Know

Vor Biopharma (VOR) Upgraded to Buy: Here's What You Should Know

The Penny Stock A-List: 7 High-Profile Companies on the Verge of Greatness

The Penny Stock A-List: 7 High-Profile Companies on the Verge of Greatness

About Vor Biopharma Inc. Common Stock

Key Executives

Fundamentals

Valuation

Profitability

Trading

Technical indicators

Analyst views

Seasonality

Compare stocks

Market cap

Price / Earnings ratio

Price / Sales ratio

Dividend yield

Average volume

Earnings per share

Stocks in the same sector

FAQ

Trade Faster. Easier. Smarter.

#ReadyGoTrade